Skip to main content

NEA Approved Features

Lauren Mateja, Managing Editor
A murine model showed success in treating atopic dermatitis by activating natural killer cells instead of suppressing the immune response. The Dermatologist spoke with researcher Brian S. Kim, MD, about the future of this immunotherapeutic strategy.
Melissa Weiss, Associate Editor
Patients with eczema often wonder if their diet can affect their disease severity. In an interview with The Dermatologist, Aaron Drucker, MD, discussed his study on the role of gluten as a risk factor for inflammatory disease severity.
Esther A. Balogh, MD, Elnara Muradova, MS, Lindsay C. Strowd, MD, FAAD
Genetic polymorphisms and defects are commonly found in patients with atopic dermatitis. A more personalized therapy that considers individual genetics and pathogenesis may provide a more effective treatment approach.
Rachel Shireen Golpanian, BA, Kayla Fourzali, MS, Hong Liang Tey, MD, Gil Yosipovitch, MD
Diagnosis of atopic dermatitis in skin of color and in various age groups can be challenging. Understanding the differences in presentation can help with implementing appropriate treatment sooner.
Melissa Weiss, Associate Editor
In an interview with The Dermatologist, Andrew F. Alexis, MD, reviewed important considerations for diagnosing and treating atopic dermatitis in patients with skin of color.
Jonathan Silverberg, MD
Several studies showed associations between atopic dermatitis and various diseases and conditions, from depression to cardiovascular disease. Here is how dermatologists can translate the latest evidence on comorbidities into practice.
Jill Waldbieser, Managing Editor
Itch is one of the most common—and distressing—symptoms of atopic dermatitis, and effectively treating it requires an understanding of the underlying pathology of the disease.
Jill Waldbieser, Managing Editor
Research has barely scratched the surface of what we can learn about the relationships between immunity and inflammatory skin disease. A leading expert discusses the implications of emerging and future research on managing AD.
Jill Waldbieser, Managing Editor
Despite a burgeoning body of research about AD’s causes, symptoms, and novel treatments for the disease, some myths stubbornly persist among clinicians.
Brianna De Souza, MD, Amy J. McMichael, MD
Eczema disproportionately affects patients with skin of color, who have different presentations and treatment concerns.
Back to Top